Vermont H 676: An act relating to clean grid optimization

Bill Text

BILL AS INTRODUCED H.676
2026 Page 1 of 2

VT LEG #386207 v.1
H.676 1
Introduced by Representatives Burtt of Cabot, Bosch of Clarendon, and 2
Hooper of Burlington 3
Referred to Committee on 4
Date: 5
Subject: Health; prescription drugs; animal-derived thyroid medications; 6
desiccated thyroid extract 7
Statement of purpose of bill as introduced: This bill proposes to direct the 8
Office of Professional Regulation to consider ways to ensure that animal-9
derived thyroid medications continue to be available to Vermonters. It would 10
require the Office of Professional Regulation and the Department of Financial 11
Regulation to implement all feasible options and would require the Office to 12
report to the General Assembly with findings, recommendations, and any 13
options that would require legislative action. 14
An act relating to maintaining patient access to animal-derived thyroid 15
medications 16
It is hereby enacted by the General Assembly of the State of Vermont: 17
Sec. 1. MAINTAINING PATIENT ACCESS TO ANIMAL-DERIVED 18
THYROID MEDICATIONS; REPORT 19

BILL AS INTRODUCED H.676
2026 Page 2 of 2

VT LEG #386207 v.1
(a) The Office of Professional Regulation, in consultation with the 1
Department of Financial Regulation; representatives of health care 2
professionals, of health insurers, and of patients with hypothyroidism and other 3
thyroid-related disorders; and other interested stakeholders, shall consider all 4
options for ensuring that animal-derived thyroid medications, including 5
desiccated thyroid extract, continue to be available to patients in Vermont for 6
whom those medications are more effective or better tolerated than synthetic 7
thyroid medications. The Office of Professional Regulation and the 8
Department of Financial Regulation shall promptly implement all feasible 9
options that do not require legislative action. 10
(b) On or before January 15, 2027, the Office of Professional Regulation 11
shall report its findings and recommendations, including options already 12
implemented and any that require legislative action, to the House Committee 13
on Health Care and the Senate Committee on Health and Welfare. 14
Sec. 2. EFFECTIVE DATE 15
This act shall take effect on passage. 16